Pharmacology of Modality-Specific Transient Receptor Potential Vanilloid-1 Antagonists That Do Not Alter Body Temperature-Reference-Cited by-同舟云学术

Pharmacology of Modality-Specific Transient Receptor Potential Vanilloid-1 Antagonists That Do Not Alter Body Temperature

Published:2012-05-08 Issue:2 Volume:342 Page:416-428
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Reilly Regina M.,McDonald Heath A.,Puttfarcken Pamela S.,Joshi Shailen K.,Lewis LaGeisha,Pai Madhavi,Franklin Pamela H.,Segreti Jason A.,Neelands Torben R.,Han Ping,Chen Jun,Mantyh Patrick W.,Ghilardi Joseph R.,Turner Teresa M.,Voight Eric A.,Daanen Jerome F.,Schmidt Robert G.,Gomtsyan Arthur,Kort Michael E.,Faltynek Connie R.,Kym Philip R.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference45 articles.

1. Answering the Burning Question of How Transient Receptor Potential Vanilloid-1 Channel Antagonists Cause Unwanted Hyperthermia

2. Protons: small stimulants of capsaicin-sensitive sensory nerves

3. Impaired Nociception and Pain Sensation in Mice Lacking the Capsaicin Receptor

4. The capsaicin receptor: a heat-activated ion channel in the pain pathway

5. Pharmacological modulation of movement-evoked pain in a rat model of osteoarthritis

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Capsaicin: a spicy way in liver disease;Frontiers in Pharmacology;2024-08-30

2. Discovery of N-(1,4-Benzoxazin-3-one) urea analogs as Mode-Selective TRPV1 antagonists;Bioorganic & Medicinal Chemistry Letters;2024-07

3. TRPV1 antagonists: Future drug discovery directions;TRP Channels as Therapeutic Targets;2024

4. Transient receptor potential vanilloid 1: A potential therapeutic target for the treatment of osteoarthritis and rheumatoid arthritis;Cell Proliferation;2023-11-23

5. Expression of the Transient Receptor Potential Vanilloid 1 ion channel in the supramammillary nucleus and the antidepressant effects of its antagonist AMG9810 in mice;European Neuropsychopharmacology;2023-08